These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16580201)

  • 1. Diarylacetylene piperidinyl amides as novel anxiolytics.
    Kordik CP; Luo C; Gutherman M; Vaidya AH; Rosenthal DI; Crooke JJ; McKenney SL; Plata-Salaman CR; Reitz AB
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3065-7. PubMed ID: 16580201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
    Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
    J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity.
    Spanka C; Glatthar R; Desrayaud S; Fendt M; Orain D; Troxler T; Vranesic I
    Bioorg Med Chem Lett; 2010 Jan; 20(1):184-8. PubMed ID: 19931453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperazinyl oxime ethers as NK-1 receptor antagonists.
    van den Hoogenband A; van Maarseveen JH; McCreary AC; Mulder AT; van Scharrenburg GJ; van Stuivenberg HH; Zethof TJ; Zijta B; Iwema Bakker WI
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1045-8. PubMed ID: 16289817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutions.
    Shue HJ; Chen X; Schwerdt JH; Paliwal S; Blythin DJ; Lin L; Gu D; Wang C; Reichard GA; Wang H; Piwinski JJ; Duffy RA; Lachowicz JE; Coffin VL; Nomeir AA; Morgan CA; Varty GB; Shih NY
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1065-9. PubMed ID: 16290143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats.
    Rezvani AH; Overstreet DH; Levin ED; Rosenthal DI; Kordik CP; Reitz AB; Vaidya AH
    Alcohol Clin Exp Res; 2007 Jan; 31(1):57-63. PubMed ID: 17207102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
    Leopoldo M; Lacivita E; Colabufo NA; Contino M; Berardi F; Perrone R
    J Med Chem; 2005 Dec; 48(25):7919-22. PubMed ID: 16335915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and structure-activity relationship of 2-phenyl-oxazole-4-carboxamide derivatives as potent apoptosis inducers.
    Tai VW; Sperandio D; Shelton EJ; Litvak J; Pararajasingham K; Cebon B; Lohman J; Eksterowicz J; Kantak S; Sabbatini P; Brown C; Zeitz J; Reed C; Maske B; Graupe D; Estevez A; Oeh J; Wong D; Ni Y; Sprengeler P; Yee R; Magill C; Neri A; Cai SX; Drewe J; Qiu L; Herich J; Tseng B; Kasibhatla S; Spencer JR
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4554-8. PubMed ID: 16784854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
    Borza I; Kolok S; Gere A; Nagy J; Fodor L; Galgóczy K; Fetter J; Bertha F; Agai B; Horváth C; Farkas S; Domány G
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4638-40. PubMed ID: 16782335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of imidazole carboxamides as potent and selective CCK1R agonists.
    Zhu C; Hansen AR; Bateman T; Chen Z; Holt TG; Hubert JA; Karanam BV; Lee SJ; Pan J; Qian S; Reddy VB; Reitman ML; Strack AM; Tong V; Weingarth DT; Wolff MS; MacNeil DJ; Weber AE; Duffy JL; Edmondson SD
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4393-6. PubMed ID: 18614364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and study of anti-inflammatory activity of some novel cyclophane amides.
    Rajakumar P; Mohammed Abdul Rasheed A; Iman Rabia A; Chamundeeswari D
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6019-23. PubMed ID: 16996736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
    DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Chai L; Chaffee SC; Deak HL; Epstein LF; Faust T; Gallant P; Gore A; Gu Y; Henkle B; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; Zhao H; Zhu L; Zhu X
    J Med Chem; 2008 Mar; 51(6):1681-94. PubMed ID: 18321037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of novel cyclohexylamide CCR2 antagonists.
    Lanter JC; Markotan TP; Zhang X; Subasinghe N; Kang FA; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Molloy CJ; Sui Z
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7496-501. PubMed ID: 22061641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies in the search for anxiolytics.
    File SE
    Drug Des Deliv; 1990 Mar; 5(3):195-201. PubMed ID: 1688319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites formation.
    Kawai M; Sakurada I; Morita A; Iwamuro Y; Ando K; Omura H; Sakakibara S; Masuda T; Koike H; Honma T; Hattori K; Takashima T; Mizuno K; Mizutani M; Kawamura M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5537-42. PubMed ID: 17766107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [1,3]Diazaheterofused isoindolol derivatives displaying anxiolytic-like effects on mice.
    Zamilpa A; Herrera-Ruiz M; Del Olmo E; López-Pérez JL; Tortoriello J; San Feliciano A
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4016-21. PubMed ID: 17507222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Goodacre SC; Hallett DJ; Carling RW; Castro JL; Reynolds DS; Pike A; Wafford KA; Newman R; Atack JR; Street LJ
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1582-5. PubMed ID: 16384707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective synthesis and structure-activity relationship of novel ceramide trafficking inhibitors. (1R,3R)-N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl)dodecanamide and its analogues.
    Nakamura Y; Matsubara R; Kitagawa H; Kobayashi S; Kumagai K; Yasuda S; Hanada K
    J Med Chem; 2003 Aug; 46(17):3688-95. PubMed ID: 12904073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.